Cipla believes the child is the most important person in the universe of healthcare, and has unique needs which are different from that of adults. We are committed to addressing not just their needs, but also those of their parents (or caregivers) and pediatricians.
That’s why we make sure that our pediatric formulations are gentle on the system, our bottles are double-sealed, droppers are easy-to-use and the asthma kit is child-friendly…We go the extra mile and develop medicines that are critical in pediatric care. We manufacture pediatric products in various child-friendly formulations like syrups, suspension, dispersible tablets, orally disintegrating tablets, sprinkles, granules etc.
For rare diseases like Thalassemia, we make Deferiprone, the world’s first oral iron chelator and Deferasirox. For pediatric HIV, we specially created the world’s first triple drug combination (Nevirapine + Stavudine + Lamivudine) in dispersible form. We are also working on a range of dispersible/sprinkle antiretrovirals in pediatric strengths to make the treatment easy for children.
9 therapeutic segments
We are present in 9 key pediatric therapeutic segments:
- Nutritional supplements
- Allergic Rhinitis therapy
- Anti-pyretic medicines
- Surfactant therapy for premature babies
- Chelation therapy
We also work at nurturing relationships between doctor and patient, and the patient’s parents by having talent competitions for kids and baby shows, special in-clinic play areas, health camps and easy-to-follow material educating parents on their child’s illnesses.
For the medical fraternity, we conduct regular workshops, guest lectures, webcasts, camps, and update the doctor with the latest scientific publications. Special workshops are held for nurses too.
All this and more, because we believe that the smaller the patient, the greater the care he needs.